| 000 | 01440 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516182037.0 | ||
| 264 | 0 | _c20150401 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1556-0961 | ||
| 024 | 7 |
_a10.1007/s12028-013-9891-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHametner, C | |
| 245 | 0 | 0 |
_aProlonged low-dose thrombolysis in posterior circulation stroke. _h[electronic resource] |
| 260 |
_bNeurocritical care _cAug 2014 |
||
| 300 |
_a114-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBasilar Artery _xpathology |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracranial Arterial Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aIntracranial Thrombosis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKellert, L | |
| 700 | 1 | _aVeltkamp, R | |
| 700 | 1 | _aBehrens, L | |
| 700 | 1 | _aNagel, S | |
| 700 | 1 | _aHacke, W | |
| 700 | 1 | _aRingleb, P | |
| 773 | 0 |
_tNeurocritical care _gvol. 21 _gno. 1 _gp. 114-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12028-013-9891-5 _zAvailable from publisher's website |
| 999 |
_c23281882 _d23281882 |
||